Search
×

News & Events

All Events In the media Insight MiFID II Monitor News Tax Enhanced Video

More news & Insights

Burford Capital Investor Lunch

Burford Capital Investor Lunch

Events  |  01 Oct 2019
What is Business Relief?

What is Business Relief?

01 Oct 2019
Business Relief Products – The truth about what’s underneath

Business Relief Products – The truth about what’s underneath

30 Sep 2019
Pharma industry sounds the alarm over Labour’s radical plans- Dr Martin Hall in The Telegraph

Pharma industry sounds the alarm over Labour’s radical plans- Dr Martin Hall in The...

25 Sep 2019
‘MiFID II ‘unbundling’ rules working well for investors – FCA’ Investment Week features Hardman & Co CEO, Keith Hiscock

‘MiFID II ‘unbundling’ rules working well for investors – FCA’ Investment Week features Hardman...

20 Sep 2019
Life Sciences Investor Briefing Webcast

Life Sciences Investor Briefing Webcast

Video  |  18 Sep 2019
Hardman & Co spearheads initiative to support new (S)EIS funds

Hardman & Co spearheads initiative to support new (S)EIS funds

16 Sep 2019
Life Sciences Investor Briefing – Registration open now

Life Sciences Investor Briefing – Registration open now

Events  |  03 Sep 2019
Board Effectiveness- The next lever of value creation

Board Effectiveness- The next lever of value creation

19 Aug 2019
MiFID II is not working out as planned: Boosting demand for specialist providers of research

MiFID II is not working out as planned: Boosting demand for specialist providers of...

18 Aug 2019
UK Renewable Energy Infrastructure Funds

UK Renewable Energy Infrastructure Funds

18 Jul 2019  |  By Nigel Hawkins
The Telegraph: AstraZeneca dividend under threat, analysts warn

The Telegraph: AstraZeneca dividend under threat, analysts warn

01 Jul 2019  |  By Dr Martin Hall